Art
J-GLOBAL ID：201502202853520811
Reference number：15A0222761
Distribution of serum erythropoietin levels in Japanese patients with myelodysplastic syndromes
骨髄異形成症候群の日本人患者における血清エリスロポイエチン濃度の分布
Author (9)：
,
,
,
,
,
,
,
,
Material：
Volume：
101
Issue：
1
Page：
32-36
Publication year：
Jan. 2015
JST Material Number：
F0888A
ISSN：
0925-5710
CODEN：
IJHEEY
Document type：
Article
Article type：
原著論文
Country of issue：
Germany, Federal Republic of (DEU)
Language：
ENGLISH (EN)
Thesaurus term：
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
,...
Semi thesaurus term：
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
JST classification (1)：
JST classification
Category name(code) classified by JST.
Clinical hematology in general
Reference (13)：
-
Balleari E, Clavio M, Arboscello E, Bellodi A, Bruzzone A, Del Corso L, et al. Weekly standard doses of rh-EPO are highly effective for the treatment of anemic patients with low-intermediate 1 risk myelodysplastic syndromes. Leuk Res. 2011;35:1472-6.
-
Greenberg PL, Sun Z, Miller KB, Bennett JM, Tallman MS, Dewald G, et al. Treatment of myelodysplastic syndrome patients with erythropoietin with or without granulocyte colony-stimulating factor: results of a prospective randomized phase 3 trial by the Eastern Cooperative Oncology Group (E1996). Blood. 2009;114:2393-400.
-
Hellstrom-Lindberg E, Gulbrandsen N, Lindberg G, Ahlgren T, Dahl IM, Dybedal I, et al. A validated decision model for treating the anaemia of myelodysplastic syndromes with erythropoietin + granulocyte colony-stimulating factor: significant effects on quality of life. Br J Haematol. 2003;120:1037-46.
-
Italian Cooperative Study Group for rHuEpo in Myelodysplastic S, Ferrini PR, Grossi A, Vannucchi AM, Barosi G, Guarnone R, et al. A randomized double-blind placebo-controlled study with subcutaneous recombinant human erythropoietin in patients with low-risk myelodysplastic syndromes. Br J Haematol. 1998;103:1070-4.
-
Jadersten M, Montgomery SM, Dybedal I, Porwit-MacDonald A, Hellstrom-Lindberg E. Long-term outcome of treatment of anemia in MDS with erythropoietin and G-CSF. Blood. 2005;106:803-11.
ｍore...
Terms in the title (6)：
Terms in the title
Keywords automatically extracted from the title.
,
,
,
,
,
Return to Previous Page
